A connection between visceral lipomatosis and protease inhibitors and lipoatrophy and nucleoside reverse transcriptase inhibitors has been hypothesised.
Det er blevet antaget, at der er en forbindelse mellem visceral lipomatose og proteasehæmmere samt lipoatrofi og nucleosid revers transkriptase inhibitorer.